The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prognostic and predictive factors for the outcomes of clear cell sarcoma (CCS) multidisciplinary treatment: The role of lymph node involvement.
 
Pawel Teterycz
No Relationships to Disclose
 
Anna Malgorzata Czarnecka
No Relationships to Disclose
 
Aleksandra Szmajdzinska
No Relationships to Disclose
 
Magdalena Kalejta
No Relationships to Disclose
 
Mateusz Spalek
No Relationships to Disclose
 
Magdalena Rosinska
No Relationships to Disclose
 
Jan Poleszczuk
Patents, Royalties, Other Intellectual Property - Co-inventor on the US patent 9,990,715 V2 "Radiotherapy targeted to promote a systemic abscopal response".
Travel, Accommodations, Expenses - Roche
 
Tomasz Switaj
No Relationships to Disclose
 
Marcin Zdzienicki
No Relationships to Disclose
 
Slawomir Falkowski
No Relationships to Disclose
 
Piotr Rutkowski
Honoraria - Bristol-Myers Squibb; Lilly; MSD; Novartis; Pfizer; Pierre Fabre; Roche
Consulting or Advisory Role - Amgen; Blueprint Medicines; Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre
Speakers' Bureau - Lilly; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Orphan Europe; Pierre Fabre